David A. Siegel Biodesix Inc Transaction History

Two Sigma Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.32 - $2.12 $51,480 - $82,680	-39,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.69 - $5.81 $8,112 - $27,887	4,800 Added 14.04%	39,000 $66,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $8.67 $62,168 - $131,784	15,200 Added 80.0%	34,200 $181,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.78 $125,400 - $242,820	19,000 New	19,000 $156,000

56.2M

2.6K

10.1K

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $46.4M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.